Paul Yaworsky

Chief Scientific Officer at Mediar Therapeutics
Summary
Dr. Paul Yaworsky is a highly accomplished individual with a rich educational background and extensive experience in the pharmaceutical and biotechnology industries.
He pursued a Certificate in Strategy and Innovation from the prestigious Massachusetts Institute of Technology's Sloan School of Management, underscoring his interest in innovative approaches in the business world.
With a solid foundation in scientific research, Dr. Yaworsky also holds a PhD in Molecular Neuroscience from the Mayo Clinic Graduate School of Biomedical Sciences, demonstrating his expertise in the intricate workings of the human brain.
His educational journey began with a Bachelor of Science in Molecular Genetics from the esteemed University of Toronto - University College, highlighting his early passion for understanding the fundamental aspects of genetics.
Dr. Yaworsky currently serves as the Chief Scientific Officer at Mediar Therapeutics, where he plays a pivotal role in driving scientific strategy and innovation within the organization.
His previous roles at Pfizer, a leading pharmaceutical company, showcase his progressive career path and significant contributions to various research fields.
He held key positions such as Chief Operating Officer, Director of Inflammation & Immunology Research, and Director of Tissue Repair Research at Pfizer, illustrating his broad expertise in areas critical to drug discovery and development.
Dr. Yaworsky's tenure at Pfizer also included roles as Associate Director of Muscle Research and Principal Scientist in Biological Technologies, underscoring his diverse skill set and scientific acumen.
His early career as a Postdoctoral Fellow at Genetics Institute (a subsidiary of Pfizer) further enriched his research experience and laid the foundation for his subsequent impactful roles in the industry.
Overall, Dr. Yaworsky's multidisciplinary background, from molecular genetics to neuroscience and business innovation, positions him as a versatile and valuable asset in the fields of biotechnology, pharmaceuticals, and scientific leadership.